3 ms·
It's a research paper at this point. Pricing comes after FDA approval and the ability to scale. The article says it is financially viable if there are 21 patien
by thephyber 11y ago
It's a research paper at this point. Pricing comes after FDA approval and the ability to scale.
The article says it is financially viable if there are 21 patient scans done per batch. If an additional breakthrough allows more than 21 patients per batch, then end-user pricing can fall.